Companies: 10,795·Total market cap: $144.5T
Orgenesis Inc.

Orgenesis Inc.

ORGSOTCHealthcare● Active
$0.50
+$0.01(+1.02%)
Market Cap$2558779
P/E Ratio
52W High$5.89
52W Low$0.02

Orgenesis Inc.(ORGS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ORGS · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2023-122022-122021-122020-122019-12
Revenue
Revenue$0.53M$36.02M$35.50M$7.65M$33.26M
Cost of Revenue$6.25M$20.44M$28.16M$31.10M$18.12M
Gross Profit($5.72M)$15.59M$7.34M($23.45M)$15.14M
Gross Margin %(computed)43.26%20.68%-306.42%45.53%
Operating Expenses
R&D Expenses$11.09M$6.01M$36.64M$83.99M$12.46M
G&A Expenses$34.62M$16.16M$15.40M$19.35M$25.25M
Total Operating Expenses$47.91M$22.95M$50.02M$103.43M$39.74M
Operating Income($53.64M)($7.54M)($16.80M)($95.78M)($24.60M)
Operating Margin %(computed)-20.93%-47.32%-73.98%
Interest Income$0.00M$1.82M$0.00M$0.00M$0.50M
Interest Expense$2.17M$1.82M$0.37M$1.09M$0.46M
Income Before Tax($64.44M)($11.96M)($17.95M)($96.74M)($25.48M)
Income Tax Expense$0.47M$0.21M$0.11M($1.61M)$0.56M
Net Income($55.36M)($14.89M)($18.06M)($95.81M)($26.04M)
Net Margin %(computed)-41.33%-50.87%-78.30%
Per Share & EBITDA
EPS (Basic)$-1.91$-0.59$-0.74$-4.46$-1.64
Wtd Avg Shares29.01M25.10M24.27M21.32M15.91M
EBITDA($60.72M)($8.16M)($15.72M)($94.21M)($18.91M)
EBITDA Margin %(computed)-22.65%-44.27%-56.86%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Orgenesis Inc.

关于Orgenesis Inc.(ORGS)损益表

Orgenesis Inc.(ORGS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年,ORGS实现营收$0.00B,毛利润($0.01B)(毛利率-1080.19%),净利润($0.06B)(净利率-10445.47%)。

常见问题

ORGS · 4 问

Orgenesis Inc.(ORGS)2023财年营收为$0.00B,同比down98.5%。

ORGS revenueORGS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09